Patent ID: 11904017
Assignee: REGENERON PHARMACEUTICALS, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C | IPC A  C

Claim 16:
17. The method of claim 1, wherein the antibody or antigen-binding fragment thereof comprises a heavy chain CDR 1 (HCDR1) having the amino acid sequence of SEQ ID NO:2, an HCDR2 having the amino acid sequence of SEQ ID NO:3, an HCDR3 having the amino acid sequence of SEQ ID NO:4, a light chain CDR 1 (LCDR) having the amino acid sequence of SEQ ID NO:7, an LCDR2 having the amino acid sequence of SEQ ID NO:8, and an LCDR3 having the amino acid sequence of SEQ ID NO:10.